The phrase "average responders" is correct and usable in written English.
It can be used to refer to individuals or groups that typically respond in a certain way, often in the context of surveys, studies, or assessments.
Example: "In our study, we found that average responders tended to provide more conservative estimates compared to those who were more engaged."
Alternatives: "typical respondents" or "standard responders.".
The growth and dose for average responders were estimated using published growth and weight prediction algorithms in GHD and TS [ 6, 8, 9].
The average HV (annual growth) in high responders is 3 (GHD) and 2.5 (TS) cm/year above that in average responders (Fig. 2, column 1 and 5).
The growth and dose for high responders, non-responders and non-compliant patients were estimated using the predicted outcomes for average responders and the HV and dose in the patient segments (Fig. 2), and are further described in "Appendix 2".
On average, responders saw 7.6 ± 8.1 (median = 5) clients per week for individual lessons, 8.4 ± 11.5 (median = 5) clients per week for group lessons, and 2.9 ± 3.9 (median = 2) new clients per month for individual lessons.
Average responders were those with a similar response to the reference population (response from −1 to +1) and high responders are those with a response higher than the reference population, and a responsiveness that is similar to or higher than predicted (response greater than 1, responsiveness greater than −1.28).
In the model, patients with improved compliance are assumed to reach the same height as average responders (Table 2).> For low response patients with GHD, the average HV (growth) is 2.5 cm/year less than that of average response patients, although both patient segments are treated on a similar dose.
The average responder didn't just call me a dumb bitch and move on.
If there is a low correlation between the immune responses, then it is likely that a person who is a poor responder to one immunogen, will be at least an average responder to another immunogen, and therefore will be protected.
On averages, responders were 4.5 years older than non-responders, 65.6 (SD 12.6) years and 61.1 (SD 14.8) respectively, (p < 0.001).
These curves reflect a weighted average of responders and non-responders.
On average, the responders had a lower score than non-responders by 0.05 units (p < 0.001).
